Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-40.78	33.86	57.17
Graham Fair Price	28.74	23332.14	18123.98
PEG	-72.46	-0.05	0.17
Price/Book	-3.29	0.43	0.45
Price/Cash Flow	-16.71	21.49	25.80
Prices/Earnings	-43.13	12.90	-22.69
Price/Sales	-11.05	0.87	0.98
Price/FCF	-16.71	21.49	25.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	17.41	0.07	0.06
Operating Margin	4020.39	0.02	< 0.005
ROA	56.52	< 0.005	< 0.005
ROE	< 0.005	< 0.005	70.06
ROIC	< 0.005	< 0.005	7772.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.21	-0.08	166.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.99	43.23	4272.03
EPS QOQ	-1.30	2.68	106.50
FCF QOQ	1.57	0.15	-90.69
Revenue QOQ	-0.08	0.07	-2.79
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.63	106.26	-11.17
Days Sales Outstanding (DSO)	44.58	50.04	12.26
Inventory Turnover	0.75	0.85	12.58
Debt/Capitalization	0.31	0.36	14.82
Quick Ratio	0.72	0.69	-4.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	54525.33	53826.69	-1.28
Cash	2879.92	8250.16	186.47
Capex	-1864.14	-805.87	56.77
Free Cash Flow	941.90	1079.70	14.63
Revenue	24759.57	26575.54	7.33
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.22	1.59	-28.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.60	16.74	-39.33
Naive Interpretation	Member

06 - Financial Health · Weak

Rating